Jian Zhang

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial.

|Mar 04, 2026
Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study).

Ting Li, Teng Zhou, Biyun Wang

|Jul 31, 2025
Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Jian Zhang, Yanchun Meng, Biyun Wang

|Apr 18, 2023
Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.

Jian Zhang, Rujiao Liu, Shuiping Gao

|Sep 20, 2022
Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial.

Dou-Dou Li, Zhong-Hua Tao, Bi-Yun Wang

|Jun 12, 2020
Cisplatin given at three divided doses for three consecutive days in metastatic breast cancer: an alternative schedule for one full dose with comparable efficacy but less CINV and hypomagnesaemia.

Jinfeng Zhang, Mingxi Lin, Yizi Jin

Pageof 1

Frequent Collaborators

3 joint publications

Xichun Hu

1 joint publications

Bi-Yun Wang

1 joint publications

Xin Hu

1 joint publications

Teng Zhou